Compared to Q1, participants in Q4 exhibited a 27.3% higher risk of all-cause mortality ( p = 0.003), with a significant trend across quartiles (p for trend < 0.001) (Table S2).
← all excerpts
Pan-immune-inflammation value and mortality in the US adult MASLD: a nonlinear NHANES analysis.
1
—
—